Huajin Securities华发集团旗下企业公司快报/生物医药Ⅲ财务报表预测和估值数据汇总资产负债表（百万元）会计年度2020A2021A2022E2023E2024E会计年度2020A2021A2022E2023E2024E180894812427609618098107909761144现金1347599941282543营业成本59103120应收票据及应收账款199234189334279营业税金及附加12981011预付账款52810营业费用473393469549存货3447326044管理费用68107114共他流动瓷产2235686研发费用126非流动资产19772423264429683318财务费用-23长期投瓷67135233321409100282261260320368无形瓷产81889610471231145320共他非流动瓷产810113111041096108921019217522125837863371388737284280营业外收入g000流动负债59515562273658营业外支出8000短期借款00020818917522258应付票据及应付账款1084710571129所得税2521其他流动负债462145715291非流动负黄10786861932长期借款0000018314811共他非流动负债107868686EBITDA199203180236288703597446242261286318主要财务比率1601601601601602020A2021A2022E2023E2024E资本公积971985985985985成长能力17841876198421202278营业收入%)-24.10.1-2.423.617.130782889297830833218营业利润%)29.8-8.925.917.137863371388737284280归属于母公司净利润(%)31.1-193-7.324.515.8现金流量表（百万元）毛利率(%92.786.986.987.788.12020A2021A2022E2023E2024E净利率(%)22.718317.417.517.35871593-300710ROE(%)5.94.85.86.51831156196230ROIC(%)4.8524.55.86.8033341-18瓷产负债率(%)18.57.117.4-11-2020流动比率3.06.12.22.81.5营运资金变动-102-100462492471速动比率3.05.5212.31.3其他经营现金流1000219-3370.2020.20.30.3-9358-3248应收账款周转率3.43.73.7应付账款周转率0.4141.41.41.4估值比率1.150.920.861.071.24P/E29.136.138.93127.00.370.443.71-1.884.44P/B1.71.81.71.719.2418.0518.6119.2720.11EV/EBITDA19.324.625.922.717.8http://www.huajinsc.cn/请务必阅读正文之后的免责条款部分